■ CD161 モノクローナル抗体(品番:65115-1-Ig)

図1. CD161抗体とCD4抗体を用いた細胞表面マーカー解析
1X10^6 human peripheral blood lymphocytes were surface stained with APC Anti-Human CD4 (APC-65143, Clone: RPA-T4), and 1 ug Anti-Human CD161 (65115-1-Ig, Clone: HP-3G10) and FITC anti-mouse IgG1 antibody at dilution 1:200. Cells were not fixed.
図2. アイソタイプコントロール抗体とCD4抗体を用いた細胞表面マーカー解析
1X10^6 human peripheral blood lymphocytes were surface stained with APC Anti-Human CD4 (APC-65143, Clone: RPA-T4), and 1 ug mouse IgG1 isotype control and FITC anti-mouse IgG1 antibody at dilution 1:200. Cells were not fixed.
■ CD161 モノクローナル抗体(品番:FITC-65115)

図1. CD161抗体とCD4抗体を用いた細胞表面マーカー解析
1X10^6 human peripheral blood lymphocytes were surface stained with 0.50 ug APC Anti-Human CD4 APC-65143, Clone: RPA-T4) and 0.50 ug FITC Anti-Human CD161 (FITC-65115, Clone: HP-3G10). Samples were not fixed.
図2. アイソタイプコントロール抗体とCD4抗体を用いた細胞表面マーカー解析
1X10^6 human peripheral blood lymphocytes were surface stained with 0.50 ug APC Anti-Human CD4 (APC-65143, Clone: RPA-T4) and 0.50 ug FITC-mouse IgG1 isotype control. Samples were not fixed.
■ CD161 モノクローナル抗体(品番:PE-65115)

図1. CD161抗体とCD4抗体を用いた細胞表面マーカー解析
1X10^6 human peripheral blood lymphocytes were surface stained with 5.00 ul/test APC-Anti-Human CD4 (APC-65143, Clone:RPA-T4) and 5.00 ul/test PE-Anti-Human CD161 (PE-65115, Clone:HP-3G10). Samples were not fixed.
図2. アイソタイプコントロール抗体とCD4抗体を用いた細胞表面マーカー解析
1X10^6 human peripheral blood lymphocytes were surface stained with 5.00 ul/test APC-Anti-Human CD4 (APC-65143, Clone: RPA-T4) and 0.50 ug PE-mouse IgG1 isotype control. Samples were not fixed.
■ CD161 モノクローナル抗体(品番:APC-65115)

図1. CD161抗体とCD4抗体を用いた細胞表面マーカー解析
1X10^6 human peripheral blood lymphocytes were surface stained with 0.25 ug FITC Anti-Human CD4 (FITC-65143, Clone: RPA-T4) and 0.25 ug APC Anti-Human CD161 (APC-65115, Clone: HP-3G10). Samples were not fixed.
図2. アイソタイプコントロール抗体とCD4抗体を用いた細胞表面マーカー解析
1X10^6 human peripheral blood lymphocytes were surface stained with 0.25 ug FITC Anti-Human CD4 (FITC-65143, Clone: RPA-T4) and 0.25 ug APC-mouse IgG1 isotype control. Samples were not fixed.
■ CD161 モノクローナル抗体(品番:CL488-65115)

図1. CD161抗体とCD4抗体を用いた細胞表面マーカー解析
100 ul human peripheral blood were surface stained with APC-Anti-Human CD4 (APC-65143, Clone: RPA-T4) and 5.00 ul CoraLite®488-conjugated Anti-Human CD161 (CL488-65115, Clone:HP-3G10). Lymphocytes were gated for analysis. Cells were not fixed.
図2. アイソタイプコントロール抗体とCD4抗体を用いた細胞表面マーカー解析
100 ul human peripheral blood were surface stained with APC-Anti-Human CD4 (APC-65143, Clone: RPA-T4) and CoraLite®488-conjugated Mouse IgG1 isotype control antibody. Lymphocytes were gated for analysis. Cells were not fixed.
■ CD161 モノクローナル抗体(品番:CL647-65115)

図1. CD161抗体とCD4抗体を用いた細胞表面マーカー解析
100 ul human peripheral blood were surface stained with FITC-Anti-Human CD4 (FITC-65143, Clone: RPA-T4) and 5.00 ul CoraLite®647-conjugated Anti-Human CD161 (CL647-65115, Clone:HP-3G10). Lymphocytes were gated for analysis. Cells were not fixed.
図2. アイソタイプコントロール抗体とCD4抗体を用いた細胞表面マーカー解析
100 ul human peripheral blood were surface stained with FITC-Anti-Human CD4 (FITC-65143, Clone: RPA-T4) and CoraLite®647-conjugated Mouse IgG1 isotype control antibody. Lymphocytes were gated for analysis. Cells were not fixed.